Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia
- PMID: 17711777
Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia
Abstract
Reporter gene techniques have been applied toward studying the physiologic phenomena associated with tumor hypoxia, a negative prognostic indicator. The purpose of this study was to assess the potential adverse effects of hypoxic conditions on the effectiveness of four commonly used reporter genes: Renilla luciferase, monomeric red fluorescent protein, thymidine kinase, and lacZ. Tumor-forming A375 cells expressing a trifusion reporter consisting of Renilla luciferase, monomeric red fluorescent protein, and thymidine kinase were subjected to decreasing oxygen tensions and assayed for reporter expression and activity. A375 cells expressing beta-galactosidase were similarly exposed to hypoxia, with activity of the reporter monitored by cleavage of the fluorescent substrate 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one)-beta-galactoside (DDAOG). Generation of signal in in vivo tumor models expressing bioluminescent or beta-galactosidase reporters were also examined over the course of hypoxic stresses, either by tumor clamping or the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Our findings indicate that bioluminescent and fluorescent reporter activity are decreased under hypoxia despite minimal variations in protein production, whereas beta-galactosidase reporter activity per unit protein was unchanged. These results demonstrate that combining beta-galactosidase with the DDAOG optical probe may be a robust reporter system for the in vivo study of tumor hypoxia.
Similar articles
-
Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.Cancer Res. 2007 Apr 1;67(7):3085-93. doi: 10.1158/0008-5472.CAN-06-2402. Cancer Res. 2007. PMID: 17409415
-
Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice.J Nucl Med. 2009 Dec;50(12):2049-57. doi: 10.2967/jnumed.108.061234. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910419
-
Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice.Gene Ther. 2007 Nov;14(22):1587-93. doi: 10.1038/sj.gt.3303028. Epub 2007 Sep 20. Gene Ther. 2007. PMID: 17882264
-
Molecular-genetic imaging based on reporter gene expression.J Nucl Med. 2008 Jun;49 Suppl 2:164S-79S. doi: 10.2967/jnumed.107.045955. J Nucl Med. 2008. PMID: 18523072 Review.
-
Imaging tumor hypoxia by magnetic resonance methods.NMR Biomed. 2011 Jan;24(1):1-16. doi: 10.1002/nbm.1558. Epub 2010 Dec 9. NMR Biomed. 2011. PMID: 21259366 Review.
Cited by
-
Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.Cancer Lett. 2015 Jan 28;356(2 Pt B):462-9. doi: 10.1016/j.canlet.2014.09.038. Epub 2014 Oct 8. Cancer Lett. 2015. PMID: 25305449 Free PMC article.
-
High-throughput quantitative bioluminescence imaging for assessing tumor burden.Methods Mol Biol. 2009;574:37-45. doi: 10.1007/978-1-60327-321-3_4. Methods Mol Biol. 2009. PMID: 19685298 Free PMC article.
-
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.Mol Cancer Ther. 2009 Jul;8(7):1867-77. doi: 10.1158/1535-7163.MCT-09-0274. Epub 2009 Jul 7. Mol Cancer Ther. 2009. PMID: 19584228 Free PMC article.
-
Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):143-53. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 25973335 Free PMC article.
-
Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.Mol Ther. 2020 Jun 3;28(6):1392-1416. doi: 10.1016/j.ymthe.2020.03.016. Epub 2020 Mar 20. Mol Ther. 2020. PMID: 32243834 Free PMC article. Review.